- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
By Maui Now
Hawaiʻi Department of Health has received a “B” and was ranked the fifth highest in the nation for its medical marijuana program, based on a recent report card of new, regulated medical marijuana distribution programs issued by Americans for Safe Access.
The national organization’s mission is to reduce barriers to medical cannabis by creating policies to improve access for patients and researchers, using legislation, education, litigation, research and other means.
According to the report card, “Hawaiʻi is on track to become one of the best programs in the country if they continue with their timely implementation.”
The grades ranged from B+ to F-. Hawaiʻi’s “B” grade was based on 430 points out of a total 500, earning a score of 86%. The highest grade of “B+” was awarded to Illinois, with 449 points and an overall score of 89%.
The report used a point system to grade the medical marijuana programs in 44 states, the District of Columbia and US territories Guam and Puerto Rico, based on five criteria:
Patients’ rights and protection from discrimination
- Access to medicine
- Ease of navigation
- Product safety protocols
Letter-grades for all 44 states and Washington, D.C. where programs were evaluated include the following: Alabama (F-), Alaska (D-), Arizona (B-), Arkansas (B-), California (B+), Colorado (B-), Connecticut (B-), Delaware (C+), Florida (B-), Georgia (F-), Hawaiʻi (B), Illinois (B+), Iowa (F-), Kentucky (F-), Louisiana (F-), Maine (B), Maryland (C), Massachusetts (B-), Michigan (B+), Minnesota (C-), Mississippi (F-), Missouri (F-), Montana (B), Nevada (B), New Hampshire (B-), New Jersey (C), New Mexico (B), New York (C), North Carolina (F-), North Dakota (C), Ohio (B), Oklahoma (F-), Oregon (B), Pennsylvania (B-), Rhode Island (C+), South Carolina (F-), Tennessee (F-), Texas (F-), Utah (F-), Vermont (C-), Virginia (F-), Washington (C-), Wisconsin (F-), Wyoming (F-), and the District of Columbia (B-).
The complete report can be viewed online at the Americans For Safe Access website.